Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Agile Therapeutics Inc (AGRX)

Agile Therapeutics Inc (AGRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Agile Therapeutics Inc 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540 USA

P: 609-683-1880

Description:

Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 5,223
Shares Outstanding, K 4,542
Annual Sales, $ 4,100 K
Annual Net Income, $ -74,890 K
Last Quarter Sales, $ 1,760 K
Last Quarter Net Income, $ -11,770 K
60-Month Beta 1.60
% of Insider Shareholders 4.70%
% of Institutional Shareholders 27.96%
Float, K 4,329
% Float 95.30%
Short Volume Ratio 0.43

Growth:

1-Year Return -97.95%
3-Year Return -98.03%
5-Year Return -99.23%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 31.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.78 on 05/12/22
Next Earnings Date 07/25/22
Earnings Per Share ttm -26.98
EPS Growth vs. Prev Qtr 52.75%
EPS Growth vs. Prev Year 52.75%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 04/27/22

AGRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -599.24%
Return-on-Assets % -176.50%
Profit Margin % -1,826.59
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 1.33
Price/Cash Flow N/A
Price/Book 2.37
Book Value/Share 0.75
Interest Coverage -18.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar